Introduction
============

For a long time, the treatment of low rectal cancer has been a difficult problem. Treatment of low rectal cancer should not only cure the tumor but also retain anal and sexual function and improve the quality of life of patients. With the comprehension of the biological characteristics and anatomic structure of rectal cancer and the maturation of laparoscopic techniques, laparoscopic anus-preserving surgery has been widely carried out for low rectal cancer. To achieve a radical cure in the past, distal rectal cancer was resected ≥2 cm. Many patients underwent abdominal perineal resection of rectal cancer, but the 5-year survival rate of patients who underwent anal resection and pelvic lymph node dissection did not improve, and in fact, the patients had many complications.[@b1-tcrm-13-1247] Based on a large clinical pathologic data bank, only 3.6% of rectal cancer patients have tumors involving the lateral aspect of the intestinal wall invading \>2 cm. Therefore, the tumor resection margin is \<2 cm or even 1 cm, which is safe.[@b2-tcrm-13-1247] Kang et al[@b3-tcrm-13-1247] conducted a study involving laparoscopic and open surgery of T3N0-2 middle and low rectal cancers and showed that the recovery of the laparoscopic group was better than the open group, and the effect of radical resection was comparable to that of the open surgery. A prospective randomized controlled study confirmed that the safety and efficacy of laparoscopic radical resection of colorectal cancer is equivalent to open surgery.[@b4-tcrm-13-1247]

The Da Vinci robotic surgery system consists of a console, a camera arm, two or three working arms, an operation trolley, and a three-dimensional (3D) video imaging system. The working arm tip of the device can carry out six-dimensional activities. For obese patients with small pelvic and rectal tumors, the operation is more flexible and accurate. Because the Da Vinci robotic surgery system has a greater magnification (10--15 times clear 3D image), it can show better the fine anatomic structure and the choroidal blood vessels of the choroid. Visualization of the loose connective tissue space between the visceral layers of the pelvic fascia is clearer, which ensures complete resection of the mesorectum.[@b5-tcrm-13-1247] The Da Vinci robotic surgery system can facilitate dissection of the pelvic lymph nodes,[@b6-tcrm-13-1247],[@b7-tcrm-13-1247] and achieve skeletonization of the lymph nodes to protect the pelvic nerves. Sexual and urinary functions are retained, and the quality of life is improved.[@b8-tcrm-13-1247],[@b9-tcrm-13-1247] Radical surgery for rectal cancer is feasible with the Da Vinci robotic surgery system. Anus-preserving surgery for low rectal cancer or ultralow rectal cancer is simple and easy. With this background, our aim was to perform a meta-analysis of the literature to compare the short-term outcomes of robot-assisted and conventional laparoscopic surgery for anus-preserving rectal cancer.

Methods
=======

Search strategy
---------------

A search of the MEDLINE, Embase, and Ovid databases was performed for studies published before May 2016 comparing clinical or oncologic outcomes of robot-assisted and conventional laparoscopic surgery for anus-preserving rectal cancer. In addition, the abstracts published at major international conferences were manually searched. The following search terms were used: "anus reserved surgery", "intersphincteric resection", "low anterior resection", "robotic/robotic assisted versus laparoscopic rectal resection", and "robotic/robotic assisted versus laparoscopic low anterior resection".

Study selection and inclusion and exclusion criteria
----------------------------------------------------

The inclusion criteria for this meta-analysis were as follows: 1) randomized and non-randomized studies comparing patients with rectal cancer who underwent anal sphincter-preserving surgery, 2) original literature involving a comparative analysis of the therapeutic effect of robotic and laparoscopic rectal cancer resection, 3) analysis of data integrity with at least one control group of independent research to provide a detailed case count and the number of outcomes under different factors, 4) the research methods of each study were similar and the purpose of the research was consistent, and 5) the results of the study can be represented by corresponding statistical indicators.

According to the quality standard of literature proposed by Lichtenstein et al,[@b10-tcrm-13-1247] the following were considered unqualified and were excluded: 1) animal experiments; 2) literature reviews, studies with no control group, medical records report, and low-quality literature; 3) studies with sample size \<10; and 4) repeated reports of similar content by the same author, reports of too little information, and reports lacking detailed data description in the literature.

Data extraction
---------------

Two researchers obtained full-text articles of relevant studies and independently determined the criteria for inclusion. Disagreements between the two authors were resolved by discussion and consensus. If the negotiation failed, a third independent author was involved. The quality of randomized controlled trials (RCTs) was evaluated using the Cochrane Reviewer's Handbook Jadad scale,[@b11-tcrm-13-1247] and the quality of the non-randomized controlled trials (NRCTs) was evaluated by the "Methodological Items for Non-Randomized Studies" ([Figure 1](#f1-tcrm-13-1247){ref-type="fig"}).[@b12-tcrm-13-1247] Researchers initially extracted the original data from the literature and converted the data into Excel forms. Missing or incomplete data were obtained by contacting the first author. If there was no response, we acquired the data through a mathematical method, and then discarded the data. Then, we evaluated the primary data integrity to ensure that the data reflected the purpose of this study.

The main focus of this meta-analysis was to evaluate the following: intraoperative blood loss (mL)rate of circumferential resection margin (CRM) involvementconversion ratedays to first passing flatushospital stay (days)postoperative complications.

Statistical analysis
--------------------

Review Manager software (RevMan, version 5.3) provided by the Cochrane Collaboration was used to perform the meta-analysis. Continuous variables were pooled using the mean difference (MD) with a 95% confidence interval (CI), and dichotomous variables were pooled using the odds ratio (OR) and risk difference (RD) with a 95% CI. If continuous variables were reported as the median with range, we calculated the means and standard deviations according to Hozo et al.[@b13-tcrm-13-1247] Statistical heterogeneity was evaluated by *I*^2^; heterogeneity was considered high if the *I*^2^ statistic was \>50%. *P*\<0.05 was considered statistically significant. The fixed effects model was used for studies with low or moderate statistical heterogeneity, and the random effects model was used for studies with high statistical heterogeneity. Sensitivity analysis was performed by repeating the meta-analysis on the studies that were excluded.

Results
=======

Eligible studies
----------------

Using the search terms, we initially retrieved 168 publications. After carefully reviewing the abstracts and full text, we found that nine comparative studies[@b14-tcrm-13-1247]--[@b22-tcrm-13-1247] met all the inclusion criteria and were eligible for meta-analysis. The characteristics of patients in the studies included in the meta-analysis are shown in [Table 1](#t1-tcrm-13-1247){ref-type="table"}. The nine studies involved 949 patients (473 in the robot group and 476 in the laparoscopy group). The nine studies were NRCTs. The anus-preserving operation included a low anterior resection, total mesorectal excision (TME), and intersphincteric resection (ISR). The characteristics of the nine selected studies included in the meta-analysis are listed in [Table 2](#t2-tcrm-13-1247){ref-type="table"}. Of all the studies, two were conducted in Turkey,[@b14-tcrm-13-1247],[@b22-tcrm-13-1247] five in Korea,[@b15-tcrm-13-1247],[@b17-tcrm-13-1247],[@b18-tcrm-13-1247],[@b20-tcrm-13-1247],[@b21-tcrm-13-1247] one in Italy,[@b16-tcrm-13-1247] and one in the US.[@b19-tcrm-13-1247] The quality of all the studies was satisfactory. The robot group had longer operative times, lower intraoperative blood loss, shorter hospital stays, lower overall postoperative complications, and a lower open conversion rate; however, there was no difference in the rate of CRM involvement and days to return of bowel function.

Blood loss
----------

Five studies[@b14-tcrm-13-1247],[@b15-tcrm-13-1247],[@b18-tcrm-13-1247]--[@b20-tcrm-13-1247] reported the intraoperative blood loss. There was significant heterogeneity in the data in the literature (*I*^2^=84%) and no evidence of publication bias ([Figure 2](#f2-tcrm-13-1247){ref-type="fig"}). Thus, the random effects model was used, and the MD was determined. The meta-analysis ([Figure 3](#f3-tcrm-13-1247){ref-type="fig"}) showed that the robot group had a lower intraoperative blood loss (MD −41.15; 95% CI −77.51, −4.79; *P*=0.03) compared with the laparoscopy group.

CRM involvement
---------------

Six studies[@b15-tcrm-13-1247]--[@b18-tcrm-13-1247],[@b20-tcrm-13-1247],[@b21-tcrm-13-1247] reported the CRM involvement. There was no significant heterogeneity in the data in the literature (*I*^2^=34%) or publication bias ([Figure 4](#f4-tcrm-13-1247){ref-type="fig"}). The fixed effect model was used, and the RD was determined. The meta-analysis ([Figure 5](#f5-tcrm-13-1247){ref-type="fig"}) showed that the result was considered not statistically significant (RD −0.02; 95% CI −0.05, 0.01; *P*=0.23).

Conversion rate
---------------

Eight studies[@b14-tcrm-13-1247]--[@b18-tcrm-13-1247],[@b20-tcrm-13-1247]--[@b22-tcrm-13-1247] reported the conversion rate. There was significant heterogeneity in the data in the literature (*I*^2^=63%), but no evidence of publication bias ([Figure 6](#f6-tcrm-13-1247){ref-type="fig"}). Thus, the random effects model was used, and the RD was determined. The meta-analysis ([Figure 7](#f7-tcrm-13-1247){ref-type="fig"}) showed that the result was statistically significant (RD −0.05; 95% CI −0.09, −0.01; *P*=0.02).

Days to first passing flatus
----------------------------

Six studies[@b15-tcrm-13-1247],[@b17-tcrm-13-1247],[@b18-tcrm-13-1247],[@b20-tcrm-13-1247]--[@b22-tcrm-13-1247] reported the days to first passing flatus. There was significant heterogeneity in the data in the literature (*I*^2^=73%) and no evidence of publication bias. Thus, the random effects model was used, and the MD was determined. The results of the meta-analysis ([Figure 8](#f8-tcrm-13-1247){ref-type="fig"}) showed that the result was not statistically significant (MD −0.03; 95% CI −0.40, 0.34, *P*=0.89).

Hospital stay
-------------

Eight studies[@b14-tcrm-13-1247],[@b15-tcrm-13-1247],[@b17-tcrm-13-1247]--[@b22-tcrm-13-1247] reported the length of hospital stay. There was significant heterogeneity in the data in the literature (*I*^2^=75%) and no evidence of publication bias. Thus, the random effects model was used, and the MD was performed. The result of the meta-analysis ([Figure 9](#f9-tcrm-13-1247){ref-type="fig"}) showed that the result was statistically significant (MD −1.07; 95% CI −1.80, −0.33; *P*=0.005).

Operative time
--------------

Nine studies[@b14-tcrm-13-1247]--[@b22-tcrm-13-1247] reported the operative time. There was significant heterogeneity in the data in the literature (*I*^2^=96%) and no evidence of publication bias. Thus, the random effects model was used, and the MD was performed. The results of the meta-analysis ([Figure 10](#f10-tcrm-13-1247){ref-type="fig"}) showed that the result was statistically significant (MD 33.73; 95% CI 8.48, 58.99; *P*=0.009).

Postoperative complications
---------------------------

Nine studies[@b14-tcrm-13-1247]--[@b22-tcrm-13-1247] reported the postoperative complications. There was no significant heterogeneity in the data in the literature (*I*^2^=0%) or evidence of publication bias. Thus, the fixed effects model was used, and the OR was determined. The results of the meta-analysis ([Figure 11](#f11-tcrm-13-1247){ref-type="fig"}) showed that the result was statistically significant (OR 0.58; 95% CI 0.41, 0.83; *P*=0.003).

Publication bias estimate
-------------------------

We used funnel plots to evaluate all of the possible publication biases that were included in the literature.

Discussion
==========

Currently, the clinical application of robotic surgery system for colorectal cancer resection is still in the exploratory stage. Indeed, it is more difficult to implement RCTs in the surgical field. Therefore, the current meta-analysis is mainly based on NRCTs. After analyzing the basic patient data, we found that the two groups had more male patients than females. In addition, the age of the patients in the robot group was small. The Da Vinci robotic surgery system is still in the exploratory stage,[@b23-tcrm-13-1247] which may have caused the selection bias in this finding. The above two reasons also support the conclusion of our study; specifically, the robotic group had a shorter hospital stay and a lower incidence of short-term complications. The surgical approaches in studies included in this meta-analysis were total mesorectal excision[@b14-tcrm-13-1247]--[@b19-tcrm-13-1247],[@b21-tcrm-13-1247],[@b22-tcrm-13-1247] and ISR[@b20-tcrm-13-1247] for resection of rectal cancer. Erguner et al[@b14-tcrm-13-1247] included partial mesorectal excision and TME in their study.

The results of this study showed that the amount of bleeding in the robotic group was significantly less than the laparoscopic group (*P*\<0.05). The field of vision in Da Vinci surgical system is more open; thus, it is possible to visualize the microscopic blood vessels and nerves that are not easily visualized during laparoscopic surgery.[@b24-tcrm-13-1247] At the same time, operation with a robotic surgery system is flexible and free from tremor, which ensures the stability and accuracy of the operation.[@b25-tcrm-13-1247],[@b26-tcrm-13-1247] The Da Vinci surgical system allows visualization of the blood vessels around the fat and proper lymph node dissection, and the blood vessels and nerves cannot be easily damaged, resulting in higher security.

Involvement of CRM is defined as when the tumor is located ≤1 mm from the CRM.[@b27-tcrm-13-1247] A safe CRM can be achieved with the robotic system compared with the conventional laparoscopy.[@b28-tcrm-13-1247] However, the results of our study were not statistically different between the groups. Moreover, the CLASICC trial[@b29-tcrm-13-1247] also showed the same results. Park et al[@b18-tcrm-13-1247] proposed that the rate of CRM involvement is mainly influenced by two factors: the location of the tumor in the rectum and the quality of the surgery. Because the location of the tumor is random and a key factor is the quality of dissection, robotic surgery is more dominant in the macroscopic grading than conventional laparoscopic surgery. In the future, a large number of RCTs are needed for further validation.

We found no differences between the robot and laparoscopy groups in the time to first passing flatus. Rational evaluation of intestinal function and recovery of diet played a key role in shortening the length of hospital stay.

The current study showed noteworthy differences between the groups in the rate of conversion to open surgery. The laparoscopy group had a higher rate of conversion to open surgery than the robot group. A number of studies have indicated that laparoscopic surgery was difficult to perform in narrow spaces and the deep space of the cavum pelvis. Therefore, the surgeon is required to have fairly high experience and learning curve.[@b30-tcrm-13-1247]--[@b37-tcrm-13-1247] Another important issue is that laparoscopic techniques have low dexterity and does not allow flexible bending. Moreover, two-dimensional vision and the camera field of vision heavily depend on the ability of the assistant.[@b38-tcrm-13-1247],[@b39-tcrm-13-1247] The Da Vinci surgical system appears to overcome many disadvantages of laparoscopic surgery, ensuring good operational flexibility, 3D visual field, and filtering of physiological shock.[@b40-tcrm-13-1247]

Our results showed that compared with the robot group, the laparoscopy group had shorter surgical operative times. This finding may be associated with the initial operation of the Da Vinci system, which requires adjusting the position of the machine, in addition to the following: fixing the operating arm in position is time-consuming, there is lack of experience in trocar placement, the inexperienced physicians and nurses are not helpful, and the replacement of surgical instruments is time-consuming.[@b41-tcrm-13-1247] After gaining experience with various surgeries, the operation of the Da Vinci surgery system can offer the advantage of flexibility, and the operation time can also be shortened.

The biggest shortcoming with the robotic surgery system is its high cost because the acquisition and maintenance costs are higher. Due to the cost, the two groups are less frequently compared in the literature. Thus, in this study, the cost was not compared. A recent meta-analysis also showed that the cost of robotic surgery is much higher than laparoscopic surgery, and patient benefit is not apparent.[@b42-tcrm-13-1247]

Study limitations
=================

This meta-analysis has the following limitations: 1) Because of the difference in the cost of the two types of operative methods and the medical, moral, and ethical issues, it is difficult to achieve randomization and blinding. This paper mainly included non-randomized controlled studies and had selection, performance, and measurement bias. 2) The number of patients included in the literature and the number of studies were relatively small; thus, we could not carry out subgroup and sensitivity analysis. The conclusion was the credibility of the reduction. 3) The presence of confounding factors in the literature may not be resolved, resulting in bias. 4) We could not eliminate the differences in patients, and the skills and experience of surgeons between the two groups. The present study compared the short-term effect, which is not sufficient; there was no long-term curative effect to compare postoperatively. We look forward to future research and multicenter RCTs to verify our findings and provide strong evidence for clinical diagnosis and treatment.

In conclusion, compared with laparoscopic rectal cancer surgery, the robotic surgery is advantageous. Although the robotic operation requires more time, the intraoperative blood loss is less and the postoperative complication rate is low. However, in addition to being more expensive, robotic surgery has a steeper learning curve, with similar complication rates and oncologic surrogate markers of successful surgery. Therefore, further improving the medical technology level, reducing costs and improving the surgeon's proficiency, can increase the advantage of robotic surgery significantly.
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![Forest plot of operative time outcome.\
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![Forest plot of postoperative complications outcome.\
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###### 

Characteristics of patients in studies included in the meta-analysis

  Study                                 Country       Robotic and laparoscopic mean BMI   Sex (M:F)   Tumor location from anal verge (n)   Previous surgery (%)   Pre-op CRT (%)   Ileostomy (%)   Leak rate (%)               
  ------------------------------------- ------------- ----------------------------------- ----------- ------------------------------------ ---------------------- ---------------- --------------- --------------- ----------- ---------
  Erguner et al[@b14-tcrm-13-1247]      Turkey        R-LAR: 28.3                         14:13       8                                    16                     3                --              4 (14.81)       --          --
  L-LAR: 26.8                           20:17         20                                  13          4                                    --                     8 (21.62)        --              3                           
  Baek et al[@b15-tcrm-13-1247]         South Korea   R-LAR: 23.4                         31:16       --                                   --                     --               --              --              --          4 (8.5)
  L-LAR: 23.4                           28:9          --                                  --          --                                   --                     --               --              3 (8.1)                     
  D'Annibale et al[@b16-tcrm-13-1247]   Italy         --                                  30:20       8                                    9                      33               --              34              --          5 (10)
  --                                    30:20         21                                  12          17                                   --                     28               --              7 (14)                      
  Baik et al[@b17-tcrm-13-1247]         South Korea   R-LAR: 23.4                         37:19       --                                   --                     --               1 (1.8)         5 (8.9)         --          1
  L-LAR: 23.2                           34:23         --                                  --          --                                   5 (8.8)                7 (12.3)         --              4                           
  Park et al[@b18-tcrm-13-1247]         South Korea   R-LAR: 23.1                         86:47       40                                   60                     33               10 (7.5)        15 (11.3)       29 (21.8)   6
  L-LAR: 22.9                           60:24         31                                  37          16                                   11 (13.1)              10 (11.9)        20 (23.8)       3                           
  Pigazzi et al[@b19-tcrm-13-1247]      US            R-TME: 31.0                         2:4         --                                   --                     --               2               2               --          --
  L-TME: 27.0                           4:2           --                                  --          --                                   3                      2                --              --                          
  Park et al[@b20-tcrm-13-1247]         South Korea   R-ISR: 23.9                         28:12       --                                   --                     --               4 (10.0)        32 (80.0)       14 (35.0)   3
  L-ISR: 24.3                           25:15         --                                  --          --                                   8 (20.0)               20 (50.0)        6 (14.3)        2                           
  Kim and Kang[@b21-tcrm-13-1247]       South Korea   R-TME: 23.6                         70:30       19                                   49                     32               7               14 (14.0)       30 (30.0)   8 (8.2)
  L-TME: 23.5                           57:43         17                                  64          19                                   10                     7 (7.0)          27 (27.0)       11 (11.1)                   
  Serin et al[@b22-tcrm-13-1247]        Turkey        R-TME: 24.7                         14:0        --                                   --                     --               --              14              --          1
  L-TME: 26.0                           65:0          --                                  --          --                                   --                     65               --              6                           

**Abbreviations:** BMI, body mass index; CRT, chemoradiation therapy; LAR, low anterior resection; TME, total mesorectal excision; ISR, intersphincteric resection.

###### 

Characteristics of the nine selected studies included in the meta-analysis

  Study                                 Year   Country       Study size (n)   TME   Objective   Randomized   Follow-up   Intervention         
  ------------------------------------- ------ ------------- ---------------- ----- ----------- ------------ ----------- -------------- ----- ----
  Baik et al[@b17-tcrm-13-1247]         2009   South Korea   113              56    57          Yes          Yes         No             Yes   No
  Baek et al[@b15-tcrm-13-1247]         2013   South Korea   84               47    37          No           Yes         No             Yes   No
  D'Annibale et al[@b16-tcrm-13-1247]   2013   Italy         100              50    50          Yes          Yes         No             Yes   No
  Erguner et al[@b14-tcrm-13-1247]      2013   Turkey        64               27    37          No           Yes         No             Yes   No
  Park et al[@b18-tcrm-13-1247]         2015   South Korea   217              133   84          Yes          Yes         No             Yes   No
  Pigazzi et al[@b19-tcrm-13-1247]      2006   US            12               6     6           Yes          Yes         No             Yes   No
  Park et al[@b20-tcrm-13-1247]         2013   South Korea   80               40    40          No           Yes         No             Yes   No
  Kim and Kang[@b21-tcrm-13-1247]       2010   South Korea   200              100   100         Yes          Yes         No             Yes   No
  Serin et al[@b22-tcrm-13-1247]        2015   Turkey        79               14    65          Yes          Yes         No             No    No

**Abbreviations:** TME, total mesorectal excision; LAR, low anterior resection.
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